{"gene":"RALBP1","run_date":"2026-06-10T06:43:36","timeline":{"discoveries":[{"year":1995,"finding":"RLIP76 (RLIP1) was identified as a direct effector of activated RalA via its effector domain; it also contains a RhoGAP domain that displays GAP activity toward Rac1 and CDC42 but not RhoA, and this GAP region is not required for RalA binding.","method":"Two-hybrid screen, purified protein biochemical GAP assay, binding studies with purified RalA","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro biochemical GAP assay with purified proteins plus two-hybrid genetic interaction; foundational study replicated by subsequent structural and biochemical work","pmids":["7673236"],"is_preprint":false},{"year":2000,"finding":"RLIP76 is identical to the previously characterized DNP-SG ATPase and catalyzes ATP-dependent transport of glutathione conjugates (GS-HNE, LTC4, DNP-SG) and doxorubicin when reconstituted into proteoliposomes; it has inherent ATPase activity stimulated by these substrates; transfection into K562 cells confers doxorubicin resistance.","method":"cDNA cloning and sequencing; E. coli expression and purification; ATPase assays; proteoliposome reconstitution transport assays; cell transfection with drug resistance/efflux readout","journal":"Biochemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro reconstitution with purified recombinant protein plus cellular functional validation; replicated across multiple subsequent studies","pmids":["10924126"],"is_preprint":false},{"year":2000,"finding":"RLIP76 interacts with Mu2, the medium chain of the AP2 clathrin adaptor complex, both in vitro and in vivo as an endogenous complex; activated Ral interferes with transferrin receptor and EGF receptor endocytosis in HeLa cells, linking the Ral-RLIP76 pathway to clathrin-mediated endocytosis.","method":"Two-hybrid assay; co-immunoprecipitation of endogenous proteins; receptor endocytosis assay in cells expressing activated Ral","journal":"Journal of cell science","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal Co-IP of endogenous proteins plus functional endocytosis assay; replicated in subsequent studies","pmids":["10910768"],"is_preprint":false},{"year":1997,"finding":"RalBP1 binds a novel ~85 kDa EH-domain protein, Reps1, at a site distinct from the Ral-binding site; Reps1 is tyrosine-phosphorylated in response to EGF and can associate with SH3 domains of Crk and Grb2.","method":"Two-hybrid cloning; in-cell EGF stimulation/phosphorylation assay; SH3 domain binding assay","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — two-hybrid plus cell-based phosphorylation evidence; single lab, foundational study","pmids":["9395447"],"is_preprint":false},{"year":2001,"finding":"RLIP76 has two ATP-binding sites: (69)GKKKGK(74) in the N-terminal fragment and (418)GGIKDLSK(425) in the C-terminal fragment; mutation of K74 or K425 to Met abrogates ATPase activity and ATP binding; transport of doxorubicin and colchicine can be reconstituted by co-mixing N- and C-terminal fragments but not by either alone or by the ATPase-dead mutants.","method":"Deletion mutagenesis; photoaffinity labeling with 8-azido-ATP; ATPase assays; proteoliposome reconstitution transport assays","journal":"Biochemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — mutagenesis of active-site residues combined with reconstitution assays in a single rigorous study","pmids":["11300797"],"is_preprint":false},{"year":2001,"finding":"RLIP76 is the predominant ATP-dependent transporter of glutathione conjugates (GS-HNE, LTC4, DNP-SG) and doxorubicin in human erythrocytes; anti-RLIP76 antibodies inhibit ~70% of transport in inside-out vesicles, whereas anti-MRP1 or anti-Pgp antibodies have no effect.","method":"Western blot; immunohistochemistry; antibody-mediated inhibition of transport in erythrocyte inside-out vesicles","journal":"Archives of biochemistry and biophysics","confidence":"High","confidence_rationale":"Tier 2 / Strong — quantitative immunotitration of transport activity with specific antibodies in native membrane vesicles; corroborated by multiple independent studies","pmids":["11437348"],"is_preprint":false},{"year":2001,"finding":"Mild oxidative or heat stress induces RLIP76 expression in K562 and multiple other cell lines, leading to increased GS-HNE efflux; cells pre-conditioned with stress acquire resistance to 4-HNE- and H2O2-mediated apoptosis; coating cells with anti-RLIP76 IgG (blocking GS-HNE efflux) abrogates this protection, demonstrating that RLIP76-mediated GS-HNE transport is the mechanistic basis of acquired stress resistance.","method":"Western blot (induction); GS-HNE efflux assay; cell surface antibody coating; apoptosis/caspase-3 and JNK activation assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — antibody loss-of-function experiment with defined transport and apoptosis readouts; replicated across multiple cell lines","pmids":["11522795"],"is_preprint":false},{"year":2004,"finding":"Amino acids 154–219, and specifically the segment 171–185, constitute the membrane-anchoring domain of RLIP76; deletion of this region reduces hydrophobicity, membrane incorporation into liposomes, and transport activity toward doxorubicin and DNP-SG; the region co-localizes with HER2/Neu at the cell surface and is necessary for surface expression.","method":"Deletion mutagenesis; detergent/aqueous partitioning assay; proteoliposome reconstitution; confocal immunohistochemistry; siRNA depletion of endogenous RLIP76 in transfected cells","journal":"Biochemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — mutagenesis combined with reconstitution transport assays and direct localization imaging in a single study","pmids":["15610018"],"is_preprint":false},{"year":2005,"finding":"PKCα phosphorylates RLIP76 at T297 and S509; phosphorylation at T297 increases doxorubicin transport activity approximately 2-fold and confers sensitivity to tryptic cleavage at R293; RLIP76 from NSCLC (primarily phosphorylated) has ~2-fold higher specific activity for doxorubicin transport than SCLC RLIP76.","method":"Deletion mutant analysis; in vitro PKCα phosphorylation; transport activity assays with purified RLIP76 from cell lines; tryptic digest analysis","journal":"FEBS letters","confidence":"High","confidence_rationale":"Tier 1 / Moderate — site-directed mutagenesis combined with in vitro kinase assay and functional transport readout","pmids":["16087181"],"is_preprint":false},{"year":2004,"finding":"PKCα phosphorylates RLIP76 and increases its LTC4 transport activity 2–3-fold; proteoliposomes reconstituted with RLIP76 catalyze ATP-dependent LTC4 transport (Km ATP ~5.1 mM; Km LTC4 ~210 nM; Vmax ~3.2 nmol/min/mg); anti-RLIP76 antibodies inhibit 67–81% of LTC4 transport in cancer cell membrane vesicles.","method":"In vitro PKCα phosphorylation; proteoliposome reconstitution transport assays; antibody immunotitration of transport in cell membrane vesicles","journal":"International journal of cancer","confidence":"High","confidence_rationale":"Tier 1 / Moderate — reconstitution assay with kinase modification plus immunotitration in native membranes","pmids":["15386349"],"is_preprint":false},{"year":2006,"finding":"RLIP76 is a direct effector of R-Ras (binds R-Ras in a GTP-dependent manner) but does not associate with H-Ras or Rap1A; RLIP76 is required for adhesion-induced Rac activation and resulting cell spreading and migration; RLIP76 mediates these effects through adhesion-induced Arf6 GTPase activation, and activated Arf6 can bypass the requirement for RLIP76.","method":"GTP-dependent pulldown/binding assay; siRNA knockdown with cell spreading and migration assays; epistasis by Arf6 activation rescue","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — GTP-dependent direct binding combined with siRNA epistasis and Arf6 rescue in a single study","pmids":["16966426"],"is_preprint":false},{"year":2008,"finding":"HSF-1 causes specific, saturable inhibition of RLIP76 transport activity; combined HSF-1 and POB1 binding causes nearly complete inhibition; RLIP76 sequesters HSF-1 in the cellular cytoskeleton, and membrane-bound RLIP76 activity is inhibited by HSF-1.","method":"In vitro transport inhibition assays with purified proteins; over-expression of HSF-1/POB1 with apoptosis readout in lung cancer cells","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct transport inhibition assay with purified proteins plus cellular over-expression; single lab","pmids":["18474607"],"is_preprint":false},{"year":2005,"finding":"POB1 (REPS2) directly inhibits RLIP76-mediated doxorubicin and DNP-SG transport in a concentration-dependent manner through direct binding to RLIP76; a POB1 deletion mutant lacking the RLIP76-binding domain does not inhibit transport and does not cause apoptosis upon liposomal delivery to cancer cells.","method":"Purified protein transport inhibition assay; liposomal delivery of POB1 with apoptosis and drug efflux readouts; deletion mutant analysis","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct transport assay with purified proteins plus domain-deletion controls; single lab","pmids":["15707977"],"is_preprint":false},{"year":2009,"finding":"Cdc2 (CDK1) directly inhibits RLIP76-mediated transport of doxorubicin and DNP-SG in a concentration-dependent manner in reconstituted proteoliposomes; liposomal delivery of cdc2 to H358 cells increases intracellular doxorubicin accumulation and induces apoptosis.","method":"Purified protein transport inhibition assay in reconstituted liposomes; liposomal cdc2 delivery with intracellular drug accumulation and apoptosis assays","journal":"Cancer letters","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vitro reconstitution assay plus cell-based functional validation; single lab","pmids":["19375851"],"is_preprint":false},{"year":2009,"finding":"RalBP1 is translocated to synapses upon NMDA receptor activation via stimulation of RalA; NMDAR activation also dephosphorylates RalBP1, promoting its interaction with the postsynaptic scaffolding protein PSD-95; both the RalA interaction and the PSD-95 interaction are required for NMDAR-dependent AMPA receptor endocytosis and LTD, and together they are sufficient to induce AMPAR endocytosis in the absence of NMDAR activation.","method":"Co-immunoprecipitation; NMDAR activation/dephosphorylation assays; siRNA knockdown with AMPAR endocytosis and LTD electrophysiology readouts; rescue experiments","journal":"PLoS biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal Co-IP, dephosphorylation-binding assay, siRNA epistasis, and electrophysiological LTD readout in a single study","pmids":["19823667"],"is_preprint":false},{"year":2010,"finding":"The Ral-binding domain (RBD) of RLIP76 forms a coiled-coil motif; the RBD-RalB complex structure reveals that RLIP76 contacts both nucleotide-sensitive switch regions of RalB; RLIP76 competes with Sec5 and Exo84 exocyst components for Ral binding with similar affinities in vitro.","method":"NMR structure determination of RBD alone; X-ray/NMR co-structure of RBD–RalB complex; mutagenesis of RalB interface residues with affinity measurements","journal":"Structure","confidence":"High","confidence_rationale":"Tier 1 / Strong — atomic-resolution structure of protein complex plus mutagenesis validation of key interface residues","pmids":["20696399"],"is_preprint":false},{"year":2011,"finding":"Aurora A phosphorylates RALA at Ser194 during mitosis, relocalizing RALA to mitochondria where it concentrates RALBP1 and DRP1; RALBP1 is associated with cyclin B–CDK1 kinase activity that phosphorylates DRP1 Ser616; disrupting RALA or RALBP1 abolishes mitochondrial fission at mitosis, causes improper mitochondrial segregation, and reduces ATP levels.","method":"Phospho-specific antibodies; mitochondrial fractionation; siRNA knockdown with live imaging and mitochondrial fission/DRP1 localization readouts; CDK1 kinase activity co-purification assay","journal":"Nature cell biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (fractionation, imaging, kinase assay, siRNA epistasis) in a single study; highly cited; independently coherent mechanistic model","pmids":["21822277"],"is_preprint":false},{"year":2011,"finding":"RLIP76-mediated glutathione-conjugate (GS-E) transport is required for clathrin-dependent endocytosis (CDE); RLIP76 mutants deficient in GS-E binding fail to rescue CDE in RLIP76(-/-) MEFs; RLIP76 depletion blocks downstream EGF signaling in a CDE-dependent manner; RLIP76(-/-) mice are resistant to chemical carcinogenesis (benzo[a]pyrene, DMBA, phorbol esters), and this resistance can be restored by topical RLIP76 protein application.","method":"RLIP76 mutant analysis in knockout MEFs; CDE assay; EGF signaling Western blots; in vivo chemical carcinogenesis in RLIP76(-/-) mice","journal":"Molecular cancer therapeutics","confidence":"High","confidence_rationale":"Tier 2 / Strong — loss-of-function in knockout mice, mutant rescue in MEFs, and epistasis via CDE pathway; multiple orthogonal readouts","pmids":["21220488"],"is_preprint":false},{"year":2012,"finding":"RalB-dependent invadopodium formation in PDAC cells requires RalBP1/RLIP76 but not the Sec5/Exo84 exocyst effectors; the requirement for RalBP1 is independent of its RhoGAP activity but depends on its ATPase function, identifying a novel RalB→RalBP1(ATPase) signaling axis for invadopodium formation.","method":"siRNA knockdown of Ral effectors; invadopodium formation assay; RalBP1 domain-specific rescue (ATPase mutant vs GAP mutant)","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — domain-specific mutant rescue clearly separates ATPase from GAP function; clean epistasis design","pmids":["22331470"],"is_preprint":false},{"year":2012,"finding":"RLIP76 is required for angiogenesis and neovascularization of solid tumors; in RLIP76(-/-) mice tumor vascular volumes are diminished, vessels are fewer, shorter and narrower; endothelial cells from RLIP76(-/-) mice show defects in migration, proliferation, and cord formation in vitro.","method":"RLIP76(-/-) mouse tumor implantation; X-ray microcomputed tomography of tumor vasculature; isolated endothelial cell functional assays (migration, proliferation, Matrigel cord formation)","journal":"Cancer research","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic loss-of-function in mice with quantitative vascular imaging plus isolated cell mechanistic assays","pmids":["22902412"],"is_preprint":false},{"year":2012,"finding":"RalBP1 is detected in the nucleus of interphase cells via nuclear localization sequences in the N-terminal third of the protein; a C-terminal coiled-coil mediates nuclear retention in Xenopus embryos; RalBP1 localizes to the actin cytoskeleton in an active Ral-dependent manner; during mitosis it associates with the mitotic spindle and centrosome, a localization negatively regulated by active Ral.","method":"Immunolocalization of endogenous RalBP1; deletion mutant analysis; live imaging in Xenopus embryos; cell-cycle staging","journal":"FASEB journal","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — domain mapping combined with immunolocalization across multiple compartments and cell-cycle stages; no reconstitution","pmids":["22319010"],"is_preprint":false},{"year":2011,"finding":"RLIP76 in glioma cells promotes proliferation and suppresses apoptosis through a Rac1-JNK signaling mechanism; constitutively active Rac1 rescues the effects of RLIP76 siRNA; the ATPase function of RLIP76 (not its RhoGAP activity) modulates Rac1 protein levels by regulating Rac1 ubiquitylation and degradation.","method":"Stable siRNA knockdown; constitutively active Rac1 rescue; Western blot for Rac1 ubiquitylation; JNK signaling assays; xenograft model","journal":"Carcinogenesis","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — rescue epistasis experiment plus ubiquitylation assay; single lab, needs independent replication","pmids":["23276796"],"is_preprint":false},{"year":2014,"finding":"RLIP76 N-terminus (residues 1–180) binds ARNO (cytohesin-2, an Arf6 GEF); Ser29/Ser30 mutation blocks ARNO interaction and prevents RLIP76-dependent Arf6 activation, PI3K activation, cell spreading, and migration; Ser62 mutation blocks Rac1 activation without affecting ARNO interaction or Arf6 activation, indicating a second step in the pathway.","method":"Domain deletion and point mutation analysis; Co-IP; Arf6 and Rac1 activation assays; cell spreading and migration assays","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — systematic domain mapping with GTPase activation and cellular functional readouts; single lab","pmids":["25450693"],"is_preprint":false},{"year":2015,"finding":"RLIP76 acts as a scaffold at recycling endosomes (Rab11-positive) by binding activated R-Ras via residues 180–192 and ARNO via the N-terminal domain (residues 1–180); RLIP76 recruits ARNO to recycling endosomes to activate Arf6, thereby promoting cell spreading and migration.","method":"Co-IP; domain-deletion mutant analysis; Rab11 colocalization imaging; Arf6 activation assay; cell spreading/migration assays with rescue","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP and domain mapping with endosomal localization and GTPase activation readouts; single lab","pmids":["26498519"],"is_preprint":false},{"year":2014,"finding":"RLIP76 is required for HIF-1 transcriptional activity and VEGF expression/secretion in carcinoma and melanoma cells; RLIP76-depleted tumor conditioned medium cannot stimulate endothelial cell proliferation, migration, or Matrigel cord formation, and this is rescued by recombinant VEGF; RLIP76 is required for PI3-kinase activation that regulates HIF-1 activity, but does not affect HIF-1α expression or nuclear localization.","method":"siRNA knockdown; HIF-1 luciferase reporter assay; VEGF ELISA; conditioned medium transfer experiment with endothelial cell functional assays; PI3K activity assay","journal":"FASEB journal","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — siRNA epistasis with multiple functional readouts and conditioned-medium rescue; single lab","pmids":["24928198"],"is_preprint":false},{"year":2007,"finding":"Mass spectrometry identified 14 phosphorylation sites in RalBP1; 10 of the first 100 N-terminal residues are phosphorylated (9 Ser, 1 Thr); overexpression of RalB produces the largest changes in phosphorylation at S463 and S645.","method":"Mass spectrometric phosphoprotein mapping in UMUC-3 and 293T cells; RalB overexpression with comparative phosphorylation analysis","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct MS phosphosite mapping in two cell lines with functional protein overexpression comparison; single lab","pmids":["17706599"],"is_preprint":false},{"year":2011,"finding":"p53 forms a specific, saturable complex with RLIP76 (shown by co-immunoprecipitation and immunofluorescence colocalization); p53 inhibits both basal and PKCα-stimulated RLIP76-mediated transport of GS-HNE and doxorubicin; loss of p53 in neuroblastoma results in RLIP76 overexpression and enhanced transport activity.","method":"Co-immunoprecipitation of purified proteins; immunofluorescence colocalization; in vitro transport inhibition assay; comparison of p53-WT vs p53-mutant cell lines","journal":"Cancer prevention research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct protein binding confirmed by both Co-IP and imaging, plus functional transport inhibition assay; single lab","pmids":["21411502"],"is_preprint":false},{"year":2006,"finding":"PKCα-mediated mitogenesis requires RLIP76 as a downstream effector; RLIP76(-/-) MEFs are resistant to PKCα depletion-mediated growth inhibition and to the PKCα-dependent mitogen PMA; restoration of RLIP76 in RLIP76(-/-) MEFs rescues sensitivity to both effects.","method":"RLIP76(-/-) MEFs; PKCα depletion; PMA treatment; rescue with exogenous RLIP76 protein via liposomal delivery","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic knockout with defined mitogenic readout and protein rescue; single lab","pmids":["16890208"],"is_preprint":false},{"year":2020,"finding":"Affinity maturation of the RLIP76 Ral-binding domain identified substitutions that improve Ral binding >20-fold; two 1.5 Å co-crystal structures of tight-binding mutants with RalB defined key interface interactions; NMR confirmed the binding site of resulting stapled peptides on RalB; these peptides competed with multiple Ral-effector interactions in cellular lysates.","method":"Directed evolution/affinity maturation; X-ray co-crystallography (1.5 Å); NMR chemical shift mapping; competitive binding assays in cellular lysates","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — high-resolution crystal structures combined with mutagenesis affinity measurements and NMR validation in a single study","pmids":["33214225"],"is_preprint":false},{"year":2023,"finding":"Reps1 and Ralbp1 form a binary complex that recognizes vesicle-bound RalA in the exocytic pathway; RalA binding causes Reps1 release and formation of a Ralbp1–RalA binary complex; Ralbp1 selectively stabilizes GTP-bound RalA (GTP state stabilization), thereby promoting exocytosis and surface protein levels; this is distinct from classical effector function.","method":"Co-IP; GTP-dependent binding assays; surface protein level measurements; epistasis with exocyst complex","journal":"Science advances","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP and biochemical GTP-dependent binding assays define a novel GTPase regulatory mechanism; single study","pmids":["36812304"],"is_preprint":false},{"year":2022,"finding":"RLIP76 directly binds HIF-1α in the nucleus and stabilizes it by alleviating HIF-1α ubiquitination under hypoxia, thereby activating HIF-1α target glycolytic genes GLUT1 and LDHA to promote glioma glycolysis and tumor development.","method":"Co-immunoprecipitation of RLIP76 and HIF-1α; ubiquitination assay; siRNA knockdown with GLUT1/LDHA Western blots; in vivo xenograft","journal":"Molecular neurobiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP plus ubiquitination assay and functional downstream gene readouts; single lab","pmids":["35998001"],"is_preprint":false},{"year":2011,"finding":"RBD structure of RLIP76 reveals its coiled-coil binds both switch regions of RalB; the juxtaposed RhoGAP and RBD domains are held in fixed orientation by a rigid linker, allowing simultaneous engagement of Rho-family and Ral GTPases at the membrane.","method":"NMR resonance assignments; structural analysis of GAP-GBD di-domain","journal":"Biomolecular NMR assignments","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — NMR resonance assignments confirming domain arrangement; structural data without extensive mutagenesis validation in this paper alone","pmids":["21915608"],"is_preprint":false}],"current_model":"RALBP1/RLIP76 is a multifunctional effector of RalA/RalB (binding both switch regions via a coiled-coil Ral-binding domain) and R-Ras that bridges Ras-family and Rho-family signaling: its central RhoGAP domain inactivates Rac1 and CDC42; its N-terminal domain and two ATP-binding sites (GKKKGK74 and GGIKDLSK425) constitute a non-ABC transporter that actively exports glutathione-electrophile conjugates (GS-HNE, LTC4), doxorubicin, and other xenobiotics; at mitosis, Aurora A–phosphorylated RalA recruits RLIP76 and DRP1 to mitochondria where RLIP76-associated cyclin B–CDK1 phosphorylates DRP1-Ser616 to drive mitochondrial fission; RLIP76-mediated GS-E transport is mechanistically required for clathrin-dependent endocytosis and thereby regulates receptor signaling; RLIP76 scaffolds ARNO at recycling endosomes downstream of R-Ras to activate Arf6 and Rac1, driving cell spreading and migration; in neurons, regulated dephosphorylation of RLIP76 and its interaction with RalA and PSD-95 control AMPA receptor endocytosis during LTD; p53 is a direct allosteric inhibitor of RLIP76 transport activity; and RLIP76 stabilizes HIF-1α by blocking its ubiquitination, linking it to hypoxic glycolysis and tumor angiogenesis."},"narrative":{"mechanistic_narrative":"RALBP1 (RLIP76) is a multifunctional Ral effector that couples Ras-family GTPase signaling to membrane transport, endocytosis, and cytoskeletal remodeling [PMID:7673236, PMID:20696399]. It binds activated RalA/RalB through a coiled-coil Ral-binding domain that contacts both nucleotide-sensitive switch regions, competing with the Sec5 and Exo84 exocyst effectors for Ral occupancy [PMID:20696399, PMID:33214225], and its juxtaposed RhoGAP domain inactivates Rac1 and CDC42 but not RhoA [PMID:7673236, PMID:21915608]. Independently of its Ral-binding and GAP functions, RLIP76 is a non-ABC ATP-dependent transporter built from two ATP-binding sites and a membrane-anchoring domain that exports glutathione-electrophile conjugates (GS-HNE, LTC4, DNP-SG) and xenobiotics including doxorubicin; reconstitution requires intact N- and C-terminal ATPase fragments, and this activity is the predominant glutathione-conjugate efflux route in human erythrocytes [PMID:10924126, PMID:11300797, PMID:11437348, PMID:15610018]. This transport activity underlies acquired oxidative-stress resistance, drug resistance, and is mechanistically required for clathrin-dependent endocytosis and downstream EGF receptor signaling, with RLIP76-null mice resistant to chemical carcinogenesis [PMID:11522795, PMID:21220488]. RLIP76 also functions as a scaffold: as a GTP-dependent effector of R-Ras it recruits the Arf6 GEF ARNO to Rab11 recycling endosomes to activate Arf6 and Rac1, driving cell spreading and migration [PMID:16966426, PMID:25450693, PMID:26498519]; in neurons it is recruited to synapses by RalA and binds PSD-95 to drive NMDAR-dependent AMPA receptor endocytosis during long-term depression [PMID:19823667]; and at mitosis it is recruited with DRP1 to mitochondria where associated cyclin B–CDK1 phosphorylates DRP1-Ser616 to drive mitochondrial fission [PMID:21822277]. Through these activities RLIP76 supports tumor proliferation, invadopodium formation, angiogenesis, and HIF-1-driven glycolysis [PMID:22331470, PMID:22902412, PMID:24928198, PMID:35998001]. Its transport activity is regulated by PKCα phosphorylation and is directly inhibited by p53 [PMID:16087181, PMID:21411502].","teleology":[{"year":1995,"claim":"Established RALBP1 as a direct effector of activated RalA that also carries Rho-family GAP activity, defining it as a node linking Ral and Rho signaling.","evidence":"Two-hybrid screen with purified-protein GAP assays against Rac1, CDC42, and RhoA","pmids":["7673236"],"confidence":"High","gaps":["Cellular consequences of Rac1/CDC42 inactivation not defined","Did not address any transport or scaffolding function"]},{"year":2000,"claim":"Revealed that RLIP76 is identical to the DNP-SG ATPase and is an ATP-dependent transporter of glutathione conjugates and doxorubicin, a function entirely separate from its Ral effector role.","evidence":"cDNA cloning, recombinant purification, proteoliposome reconstitution transport assays, and drug-resistance transfection in K562 cells","pmids":["10924126"],"confidence":"High","gaps":["Structural basis of substrate recognition unknown","Relationship between transport and Ral binding undefined"]},{"year":2000,"claim":"Connected the Ral–RLIP76 pathway to clathrin-mediated endocytosis by identifying the AP2 adaptor subunit Mu2 as a partner.","evidence":"Two-hybrid, endogenous Co-IP, and receptor endocytosis assays in HeLa cells expressing activated Ral","pmids":["10910768"],"confidence":"High","gaps":["Did not show whether transport activity is required for endocytosis","Direct AP2-Mu2 interface not mapped"]},{"year":2001,"claim":"Defined the bipartite ATPase architecture (two ATP-binding sites) required for transport, showing reconstitution needs both N- and C-terminal fragments.","evidence":"Deletion mutagenesis, 8-azido-ATP photoaffinity labeling, and proteoliposome reconstitution of doxorubicin/colchicine transport","pmids":["11300797"],"confidence":"High","gaps":["No atomic structure of the transport module","Stoichiometry of the functional transporter unresolved"]},{"year":2001,"claim":"Quantified RLIP76 as the dominant glutathione-conjugate/doxorubicin transporter in native erythrocyte membranes, distinguishing it from MRP1 and Pgp.","evidence":"Antibody immunotitration of transport in erythrocyte inside-out vesicles","pmids":["11437348"],"confidence":"High","gaps":["Contribution in other tissues not quantified in this study"]},{"year":2001,"claim":"Demonstrated that RLIP76-mediated GS-HNE efflux is the mechanistic basis of stress-induced apoptosis resistance, linking the transporter to cellular stress adaptation.","evidence":"Stress-induced expression, GS-HNE efflux assays, and anti-RLIP76 surface-coating loss-of-function with apoptosis readouts across cell lines","pmids":["11522795"],"confidence":"High","gaps":["Transcriptional control of stress induction not defined"]},{"year":2004,"claim":"Mapped the membrane-anchoring domain (residues 154–219) needed for membrane incorporation, surface expression, and transport.","evidence":"Deletion mutagenesis, partitioning assays, reconstitution, and confocal colocalization with HER2/Neu","pmids":["15610018"],"confidence":"High","gaps":["Topology of membrane insertion not resolved"]},{"year":2005,"claim":"Identified PKCα phosphorylation at T297/S509 as a positive regulator of transport activity, providing a signaling input to drug efflux.","evidence":"In vitro PKCα phosphorylation, site mutagenesis, and transport assays comparing NSCLC vs SCLC RLIP76","pmids":["16087181","15386349"],"confidence":"High","gaps":["In vivo phosphorylation stoichiometry not measured","Structural effect of phosphorylation on transport unknown"]},{"year":2006,"claim":"Established RLIP76 as a GTP-dependent R-Ras effector required for adhesion-induced Rac and Arf6 activation, driving cell spreading and migration.","evidence":"GTP-dependent pulldowns, siRNA knockdown with spreading/migration assays, and Arf6 rescue epistasis","pmids":["16966426"],"confidence":"High","gaps":["Mechanism linking RLIP76 to Arf6 activation not yet molecular"]},{"year":2009,"claim":"Defined a neuronal role: RalA-driven synaptic recruitment and dephosphorylation-dependent PSD-95 binding control AMPAR endocytosis during LTD.","evidence":"Co-IP, dephosphorylation-binding assays, siRNA rescue, and LTD electrophysiology","pmids":["19823667"],"confidence":"High","gaps":["Phosphatase responsible for dephosphorylation not identified","Link to the transport/endocytosis machinery not resolved"]},{"year":2010,"claim":"Solved the Ral-binding domain structure, showing a coiled-coil that engages both RalB switch regions and competes with exocyst effectors.","evidence":"NMR/X-ray structures of RBD and RBD–RalB complex with interface mutagenesis and affinity measurements","pmids":["20696399","21915608"],"confidence":"High","gaps":["Functional consequences of effector competition in cells not quantified"]},{"year":2011,"claim":"Demonstrated that GS-E transport activity is mechanistically required for clathrin-dependent endocytosis and EGF signaling, and that RLIP76 loss confers carcinogenesis resistance in vivo.","evidence":"Mutant rescue in RLIP76(-/-) MEFs, CDE assays, EGF signaling blots, and chemical carcinogenesis in knockout mice","pmids":["21220488"],"confidence":"High","gaps":["Molecular link between glutathione-conjugate flux and clathrin machinery unresolved"]},{"year":2011,"claim":"Defined the mitotic mitochondrial-fission axis in which Aurora A–phosphorylated RalA recruits RLIP76 and DRP1, with associated cyclin B–CDK1 phosphorylating DRP1-Ser616.","evidence":"Phospho-specific antibodies, mitochondrial fractionation, live imaging, CDK1 kinase co-purification, and siRNA epistasis","pmids":["21822277"],"confidence":"High","gaps":["How RLIP76 physically tethers cyclin B–CDK1 to DRP1 not defined"]},{"year":2012,"claim":"Separated RLIP76 functions in cancer, showing its ATPase (not GAP) activity drives RalB-dependent invadopodium formation and tumor angiogenesis.","evidence":"Domain-specific rescue in PDAC invadopodium assays and RLIP76(-/-) mouse tumor vasculature with isolated endothelial cell assays","pmids":["22331470","22902412"],"confidence":"High","gaps":["Transport substrate relevant to invadopodia/angiogenesis not identified"]},{"year":2014,"claim":"Identified ARNO (cytohesin-2) as an N-terminal partner and dissected phosphosite-controlled steps for Arf6 versus Rac1 activation in spreading and migration.","evidence":"Domain mapping, point mutation (Ser29/30, Ser62), Co-IP, and GTPase activation/cell motility assays","pmids":["25450693"],"confidence":"Medium","gaps":["Single lab","Kinases controlling these serines not identified"]},{"year":2015,"claim":"Showed RLIP76 acts as a recycling-endosome scaffold bridging activated R-Ras and ARNO to localize Arf6 activation, integrating earlier transport and migration findings.","evidence":"Co-IP, domain mapping, Rab11 colocalization, and Arf6/migration rescue assays","pmids":["26498519"],"confidence":"Medium","gaps":["Single lab","Relationship to the transport-dependent endocytosis role not reconciled"]},{"year":2022,"claim":"Linked RLIP76 to hypoxic metabolism by showing it directly binds and stabilizes HIF-1α to activate GLUT1/LDHA and promote glioma glycolysis.","evidence":"Co-IP, ubiquitination assays, siRNA with GLUT1/LDHA blots, and xenografts","pmids":["35998001"],"confidence":"Medium","gaps":["Single lab","Mechanism by which RLIP76 blocks HIF-1α ubiquitination unresolved","Apparent tension with earlier report that RLIP76 does not affect HIF-1α expression/localization (24928198) not reconciled"]},{"year":2023,"claim":"Revealed a non-effector GTPase-regulatory mode in which a Reps1–Ralbp1 complex selectively stabilizes GTP-bound RalA on exocytic vesicles to promote surface protein delivery.","evidence":"Co-IP, GTP-dependent binding, surface protein measurements, and exocyst epistasis","pmids":["36812304"],"confidence":"Medium","gaps":["Single study","Structural basis of GTP-state stabilization unknown"]},{"year":null,"claim":"How RLIP76's distinct activities — glutathione-conjugate transport, RhoGAP, Ral/R-Ras effector scaffolding, and GTP-state stabilization — are spatially and temporally coordinated within a single protein remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No full-length structure integrating transport, GAP, and Ral-binding modules","Mechanistic link between glutathione-conjugate flux and clathrin endocytosis unexplained","Physiological hierarchy among transport vs scaffold functions in vivo undefined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140657","term_label":"ATP-dependent activity","supporting_discovery_ids":[1,4,5,9]},{"term_id":"GO:0005215","term_label":"transporter activity","supporting_discovery_ids":[1,4,5,7,9]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[0,29]},{"term_id":"GO:0060089","term_label":"molecular transducer activity","supporting_discovery_ids":[0,10,15]},{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[22,23,14]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[7,5]},{"term_id":"GO:0005768","term_label":"endosome","supporting_discovery_ids":[23,2]},{"term_id":"GO:0005739","term_label":"mitochondrion","supporting_discovery_ids":[16]},{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[20,30]},{"term_id":"GO:0005856","term_label":"cytoskeleton","supporting_discovery_ids":[20,11]},{"term_id":"GO:0005815","term_label":"microtubule organizing center","supporting_discovery_ids":[20]}],"pathway":[{"term_id":"R-HSA-5653656","term_label":"Vesicle-mediated transport","supporting_discovery_ids":[2,17]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[0,10,22,23]},{"term_id":"R-HSA-382551","term_label":"Transport of small molecules","supporting_discovery_ids":[1,4,5]},{"term_id":"R-HSA-1640170","term_label":"Cell Cycle","supporting_discovery_ids":[16]},{"term_id":"R-HSA-112316","term_label":"Neuronal System","supporting_discovery_ids":[14]}],"complexes":[],"partners":["RALA","RALB","RRAS","REPS1","REPS2","PSD95","ARNO","TP53"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q15311","full_name":"RalA-binding protein 1","aliases":["76 kDa Ral-interacting protein","Dinitrophenyl S-glutathione ATPase","DNP-SG ATPase","Ral-interacting protein 1"],"length_aa":655,"mass_kda":76.1,"function":"Multifunctional protein that functions as a downstream effector of RALA and RALB (PubMed:7673236). As a GTPase-activating protein/GAP can inactivate CDC42 and RAC1 by stimulating their GTPase activity (PubMed:7673236). As part of the Ral signaling pathway, may also regulate ligand-dependent EGF and insulin receptors-mediated endocytosis (PubMed:10910768, PubMed:12775724). During mitosis, may act as a scaffold protein in the phosphorylation of EPSIN/EPN1 by the mitotic kinase cyclin B-CDK1, preventing endocytosis during that phase of the cell cycle (PubMed:12775724). During mitosis, also controls mitochondrial fission as an effector of RALA (PubMed:21822277). Recruited to mitochondrion by RALA, acts as a scaffold to foster the mitotic kinase cyclin B-CDK1-mediated phosphorylation and activation of DNM1L (PubMed:21822277) Could also function as a primary ATP-dependent active transporter for glutathione conjugates of electrophiles. May also actively catalyze the efflux of a wide range of substrates including xenobiotics like doxorubicin (DOX) contributing to cell multidrug resistance","subcellular_location":"Cell membrane; Cytoplasm, cytosol; Cytoplasm, cytoskeleton, spindle pole; Nucleus; Mitochondrion","url":"https://www.uniprot.org/uniprotkb/Q15311/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/RALBP1","classification":"Not Classified","n_dependent_lines":11,"n_total_lines":1208,"dependency_fraction":0.009105960264900662},"opencell":{"profiled":true,"resolved_as":"","ensg_id":"ENSG00000017797","cell_line_id":"CID000598","localizations":[{"compartment":"cytoplasmic","grade":3},{"compartment":"membrane","grade":3},{"compartment":"cell_contact","grade":1}],"interactors":[{"gene":"AAK1","stoichiometry":10.0},{"gene":"REPS1","stoichiometry":10.0},{"gene":"AP2M1","stoichiometry":4.0},{"gene":"AP2S1","stoichiometry":4.0},{"gene":"MAPRE1","stoichiometry":0.2},{"gene":"REPS2","stoichiometry":0.2},{"gene":"AP2B1","stoichiometry":0.2},{"gene":"CCDC82","stoichiometry":0.2},{"gene":"AP2A1","stoichiometry":0.2},{"gene":"AP2A2","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/target/CID000598","total_profiled":1310},"omim":[{"mim_id":"617916","title":"NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 7; NBIA7","url":"https://www.omim.org/entry/617916"},{"mim_id":"615283","title":"EXOCYST COMPLEX COMPONENT 8; EXOC8","url":"https://www.omim.org/entry/615283"},{"mim_id":"614825","title":"RALBP1-ASSOCIATED EPS DOMAIN-CONTAINING PROTEIN 1; REPS1","url":"https://www.omim.org/entry/614825"},{"mim_id":"609411","title":"SYNAPTOJANIN 2-BINDING PROTEIN; SYNJ2BP","url":"https://www.omim.org/entry/609411"},{"mim_id":"607262","title":"EPSIN 1; EPN1","url":"https://www.omim.org/entry/607262"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"},{"location":"Plasma membrane","reliability":"Supported"},{"location":"Nuclear bodies","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/RALBP1"},"hgnc":{"alias_symbol":["RLIP76","RIP1","RIP"],"prev_symbol":[]},"alphafold":{"accession":"Q15311","domains":[{"cath_id":"1.10.555.10","chopping":"195-370","consensus_level":"high","plddt":89.3679,"start":195,"end":370}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q15311","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q15311-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q15311-F1-predicted_aligned_error_v6.png","plddt_mean":65.06},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=RALBP1","jax_strain_url":"https://www.jax.org/strain/search?query=RALBP1"},"sequence":{"accession":"Q15311","fasta_url":"https://rest.uniprot.org/uniprotkb/Q15311.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q15311/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q15311"}},"corpus_meta":[{"pmid":"21822277","id":"PMC_21822277","title":"RALA and RALBP1 regulate mitochondrial fission at mitosis.","date":"2011","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/21822277","citation_count":306,"is_preprint":false},{"pmid":"7673236","id":"PMC_7673236","title":"Bridging Ral GTPase to Rho pathways. RLIP76, a Ral effector with CDC42/Rac GTPase-activating protein activity.","date":"1995","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/7673236","citation_count":292,"is_preprint":false},{"pmid":"10910768","id":"PMC_10910768","title":"RLIP76, an effector of the GTPase Ral, interacts with the AP2 complex: involvement of the Ral pathway in receptor endocytosis.","date":"2000","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/10910768","citation_count":152,"is_preprint":false},{"pmid":"11522795","id":"PMC_11522795","title":"Accelerated metabolism and exclusion of 4-hydroxynonenal through induction of RLIP76 and hGST5.8 is an early adaptive response of cells to heat and oxidative stress.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11522795","citation_count":151,"is_preprint":false},{"pmid":"10924126","id":"PMC_10924126","title":"Novel function of human RLIP76: ATP-dependent transport of glutathione conjugates and doxorubicin.","date":"2000","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10924126","citation_count":137,"is_preprint":false},{"pmid":"9395447","id":"PMC_9395447","title":"An Eps homology (EH) domain protein that binds to the Ral-GTPase target, RalBP1.","date":"1997","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9395447","citation_count":106,"is_preprint":false},{"pmid":"12866021","id":"PMC_12866021","title":"Transport of glutathione conjugates and chemotherapeutic drugs by RLIP76 (RALBP1): a novel link between G-protein and tyrosine kinase signaling and drug resistance.","date":"2003","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/12866021","citation_count":100,"is_preprint":false},{"pmid":"17483352","id":"PMC_17483352","title":"Regression of lung and colon cancer xenografts by depleting or inhibiting RLIP76 (Ral-binding protein 1).","date":"2007","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/17483352","citation_count":95,"is_preprint":false},{"pmid":"16489041","id":"PMC_16489041","title":"Regression of melanoma in a murine model by RLIP76 depletion.","date":"2006","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/16489041","citation_count":94,"is_preprint":false},{"pmid":"16024601","id":"PMC_16024601","title":"RLIP76 is a major determinant of radiation sensitivity.","date":"2005","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/16024601","citation_count":83,"is_preprint":false},{"pmid":"18628450","id":"PMC_18628450","title":"RLIP76 and Cancer.","date":"2008","source":"Clinical cancer research : an official journal of the American Association for Cancer Research","url":"https://pubmed.ncbi.nlm.nih.gov/18628450","citation_count":77,"is_preprint":false},{"pmid":"15705900","id":"PMC_15705900","title":"RLIP76 transports vinorelbine and mediates drug resistance in non-small cell lung cancer.","date":"2005","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/15705900","citation_count":71,"is_preprint":false},{"pmid":"11300797","id":"PMC_11300797","title":"Functional reassembly of ATP-dependent xenobiotic transport by the N- and C-terminal domains of RLIP76 and identification of ATP binding sequences.","date":"2001","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11300797","citation_count":65,"is_preprint":false},{"pmid":"19417134","id":"PMC_19417134","title":"RLIP76: a target for kidney cancer therapy.","date":"2009","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/19417134","citation_count":64,"is_preprint":false},{"pmid":"12433796","id":"PMC_12433796","title":"RLIP76, a novel transporter catalyzing ATP-dependent efflux of xenobiotics.","date":"2002","source":"Drug metabolism and disposition: the biological fate of chemicals","url":"https://pubmed.ncbi.nlm.nih.gov/12433796","citation_count":63,"is_preprint":false},{"pmid":"16966426","id":"PMC_16966426","title":"RLIP76 (RalBP1) is an R-Ras effector that mediates adhesion-dependent Rac activation and cell migration.","date":"2006","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/16966426","citation_count":63,"is_preprint":false},{"pmid":"17993611","id":"PMC_17993611","title":"Autoantibodies to the C-terminal subunit of RLIP76 induce oxidative stress and endothelial cell apoptosis in immune-mediated vascular diseases and atherosclerosis.","date":"2007","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/17993611","citation_count":63,"is_preprint":false},{"pmid":"15950949","id":"PMC_15950949","title":"Depletion of RLIP76 sensitizes lung cancer cells to doxorubicin.","date":"2005","source":"Biochemical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/15950949","citation_count":59,"is_preprint":false},{"pmid":"21220488","id":"PMC_21220488","title":"Glutathione-conjugate transport by RLIP76 is required for clathrin-dependent endocytosis and chemical carcinogenesis.","date":"2011","source":"Molecular cancer therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/21220488","citation_count":58,"is_preprint":false},{"pmid":"11437348","id":"PMC_11437348","title":"RLIP76 is the major ATP-dependent transporter of glutathione-conjugates and doxorubicin in human erythrocytes.","date":"2001","source":"Archives of biochemistry and biophysics","url":"https://pubmed.ncbi.nlm.nih.gov/11437348","citation_count":57,"is_preprint":false},{"pmid":"16188027","id":"PMC_16188027","title":"RLIP76, a non-ABC transporter, and drug resistance in epilepsy.","date":"2005","source":"BMC neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/16188027","citation_count":56,"is_preprint":false},{"pmid":"19073149","id":"PMC_19073149","title":"Regression of prostate cancer xenografts by RLIP76 depletion.","date":"2008","source":"Biochemical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/19073149","citation_count":56,"is_preprint":false},{"pmid":"22331470","id":"PMC_22331470","title":"The RalB small GTPase mediates formation of invadopodia through a GTPase-activating protein-independent function of the RalBP1/RLIP76 effector.","date":"2012","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/22331470","citation_count":56,"is_preprint":false},{"pmid":"12632060","id":"PMC_12632060","title":"Role of RLIP76 in lung cancer doxorubicin resistance: II. Doxorubicin transport in lung cancer by RLIP76.","date":"2003","source":"International journal of oncology","url":"https://pubmed.ncbi.nlm.nih.gov/12632060","citation_count":56,"is_preprint":false},{"pmid":"21671802","id":"PMC_21671802","title":"Gender disparity in susceptibility to oxidative stress and apoptosis induced by autoantibodies specific to RLIP76 in vascular cells.","date":"2011","source":"Antioxidants & redox signaling","url":"https://pubmed.ncbi.nlm.nih.gov/21671802","citation_count":55,"is_preprint":false},{"pmid":"19823667","id":"PMC_19823667","title":"Regulated RalBP1 binding to RalA and PSD-95 controls AMPA receptor endocytosis and LTD.","date":"2009","source":"PLoS biology","url":"https://pubmed.ncbi.nlm.nih.gov/19823667","citation_count":54,"is_preprint":false},{"pmid":"21170262","id":"PMC_21170262","title":"RalBP1 is necessary for metastasis of human cancer cell lines.","date":"2010","source":"Neoplasia (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/21170262","citation_count":54,"is_preprint":false},{"pmid":"19626587","id":"PMC_19626587","title":"Rlip76 transports sunitinib and sorafenib and mediates drug resistance in kidney cancer.","date":"2010","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/19626587","citation_count":53,"is_preprint":false},{"pmid":"18474607","id":"PMC_18474607","title":"Hsf-1 and POB1 induce drug sensitivity and apoptosis by inhibiting Ralbp1.","date":"2008","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18474607","citation_count":51,"is_preprint":false},{"pmid":"22902412","id":"PMC_22902412","title":"RALBP1/RLIP76 depletion in mice suppresses tumor growth by inhibiting tumor neovascularization.","date":"2012","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/22902412","citation_count":51,"is_preprint":false},{"pmid":"23276796","id":"PMC_23276796","title":"RLIP76 is overexpressed in human glioblastomas and is required for proliferation, tumorigenesis and suppression of apoptosis.","date":"2012","source":"Carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/23276796","citation_count":51,"is_preprint":false},{"pmid":"12632061","id":"PMC_12632061","title":"Role of RLIP76 in lung cancer doxorubicin resistance: III. Anti-RLIP76 antibodies trigger apoptosis in lung cancer cells and synergistically increase doxorubicin cytotoxicity.","date":"2003","source":"International journal of oncology","url":"https://pubmed.ncbi.nlm.nih.gov/12632061","citation_count":51,"is_preprint":false},{"pmid":"18983828","id":"PMC_18983828","title":"RLIP76: A novel glutathione-conjugate and multi-drug transporter.","date":"2008","source":"Biochemical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/18983828","citation_count":50,"is_preprint":false},{"pmid":"12527936","id":"PMC_12527936","title":"Role of RLIP76 in lung cancer doxorubicin resistance: I. The ATPase activity of RLIP76 correlates with doxorubicin and 4-hydroxynonenal resistance in lung cancer cells.","date":"2003","source":"International journal of oncology","url":"https://pubmed.ncbi.nlm.nih.gov/12527936","citation_count":49,"is_preprint":false},{"pmid":"18793957","id":"PMC_18793957","title":"RLIP76 in defense of radiation poisoning.","date":"2008","source":"International journal of radiation oncology, biology, physics","url":"https://pubmed.ncbi.nlm.nih.gov/18793957","citation_count":47,"is_preprint":false},{"pmid":"15610018","id":"PMC_15610018","title":"Identification of membrane-anchoring domains of RLIP76 using deletion mutant analyses.","date":"2004","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15610018","citation_count":46,"is_preprint":false},{"pmid":"15707977","id":"PMC_15707977","title":"POB1 over-expression inhibits RLIP76-mediated transport of glutathione-conjugates, drugs and promotes apoptosis.","date":"2005","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/15707977","citation_count":43,"is_preprint":false},{"pmid":"17504221","id":"PMC_17504221","title":"The non-ABC drug transporter RLIP76 (RALBP-1) plays a major role in the mechanisms of drug resistance.","date":"2007","source":"Current drug metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/17504221","citation_count":42,"is_preprint":false},{"pmid":"20097178","id":"PMC_20097178","title":"RLIP76: a versatile transporter and an emerging target for cancer therapy.","date":"2010","source":"Biochemical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/20097178","citation_count":40,"is_preprint":false},{"pmid":"21931813","id":"PMC_21931813","title":"RLIP76, a glutathione-conjugate transporter, plays a major role in the pathogenesis of metabolic syndrome.","date":"2011","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/21931813","citation_count":40,"is_preprint":false},{"pmid":"15386349","id":"PMC_15386349","title":"RLIP76 (RALBP1)-mediated transport of leukotriene C4 (LTC4) in cancer cells: implications in drug resistance.","date":"2004","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/15386349","citation_count":39,"is_preprint":false},{"pmid":"23292182","id":"PMC_23292182","title":"Knockdown of RLIP76 expression by RNA interference inhibits invasion, induces cell cycle arrest, and increases chemosensitivity to the anticancer drug temozolomide in glioma cells.","date":"2013","source":"Journal of neuro-oncology","url":"https://pubmed.ncbi.nlm.nih.gov/23292182","citation_count":39,"is_preprint":false},{"pmid":"22509328","id":"PMC_22509328","title":"RLIP76 regulates PI3K/Akt signaling and chemo-radiotherapy resistance in pancreatic cancer.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22509328","citation_count":37,"is_preprint":false},{"pmid":"17273774","id":"PMC_17273774","title":"Doxorubicin transport by RALBP1 and ABCG2 in lung and breast cancer.","date":"2007","source":"International journal of oncology","url":"https://pubmed.ncbi.nlm.nih.gov/17273774","citation_count":36,"is_preprint":false},{"pmid":"20696399","id":"PMC_20696399","title":"The RalB-RLIP76 complex reveals a novel mode of ral-effector interaction.","date":"2010","source":"Structure (London, England : 1993)","url":"https://pubmed.ncbi.nlm.nih.gov/20696399","citation_count":36,"is_preprint":false},{"pmid":"26067553","id":"PMC_26067553","title":"RLIP76-dependent suppression of PI3K/AKT/Bcl-2 pathway by miR-101 induces apoptosis in prostate cancer.","date":"2015","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/26067553","citation_count":33,"is_preprint":false},{"pmid":"16087181","id":"PMC_16087181","title":"The role of PKCalpha and RLIP76 in transport-mediated doxorubicin-resistance in lung cancer.","date":"2005","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/16087181","citation_count":31,"is_preprint":false},{"pmid":"27657824","id":"PMC_27657824","title":"Upregulation of miR-124 by physcion 8-O-β-glucopyranoside inhibits proliferation and invasion of malignant melanoma cells via repressing RLIP76.","date":"2016","source":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","url":"https://pubmed.ncbi.nlm.nih.gov/27657824","citation_count":30,"is_preprint":false},{"pmid":"24928198","id":"PMC_24928198","title":"RLIP76 regulates HIF-1 activity, VEGF expression and secretion in tumor cells, and secretome transactivation of endothelial cells.","date":"2014","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/24928198","citation_count":26,"is_preprint":false},{"pmid":"19082490","id":"PMC_19082490","title":"Functional reconstitution of RLIP76 catalyzing ATP-dependent transport of glutathione-conjugates.","date":"2009","source":"International journal of oncology","url":"https://pubmed.ncbi.nlm.nih.gov/19082490","citation_count":24,"is_preprint":false},{"pmid":"34831336","id":"PMC_34831336","title":"RALBP1 in Oxidative Stress and Mitochondrial Dysfunction in Alzheimer's Disease.","date":"2021","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/34831336","citation_count":23,"is_preprint":false},{"pmid":"12545192","id":"PMC_12545192","title":"Transport functions and physiological significance of 76 kDa Ral-binding GTPase activating protein (RLIP76).","date":"2002","source":"Acta biochimica Polonica","url":"https://pubmed.ncbi.nlm.nih.gov/12545192","citation_count":23,"is_preprint":false},{"pmid":"21411502","id":"PMC_21411502","title":"Targeting p53-null neuroblastomas through RLIP76.","date":"2011","source":"Cancer prevention research (Philadelphia, Pa.)","url":"https://pubmed.ncbi.nlm.nih.gov/21411502","citation_count":22,"is_preprint":false},{"pmid":"16890208","id":"PMC_16890208","title":"Mitogenic and drug-resistance mediating effects of PKCalpha require RLIP76.","date":"2006","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/16890208","citation_count":22,"is_preprint":false},{"pmid":"19375851","id":"PMC_19375851","title":"Increased expression of cdc2 inhibits transport function of RLIP76 and promotes apoptosis.","date":"2009","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/19375851","citation_count":22,"is_preprint":false},{"pmid":"28682430","id":"PMC_28682430","title":"miR-340 suppresses tumor growth and enhances chemosensitivity of colorectal cancer by targeting RLIP76.","date":"2017","source":"European review for medical and pharmacological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/28682430","citation_count":22,"is_preprint":false},{"pmid":"12422239","id":"PMC_12422239","title":"Functional reconstitution of Ral-binding GTPase activating protein, RLIP76, in proteoliposomes catalyzing ATP-dependent transport of glutathione conjugate of 4-hydroxynonenal.","date":"2002","source":"Acta biochimica Polonica","url":"https://pubmed.ncbi.nlm.nih.gov/12422239","citation_count":22,"is_preprint":false},{"pmid":"17437410","id":"PMC_17437410","title":"Lack of support for a role for RLIP76 (RALBP1) in response to treatment or predisposition to epilepsy.","date":"2007","source":"Epilepsia","url":"https://pubmed.ncbi.nlm.nih.gov/17437410","citation_count":21,"is_preprint":false},{"pmid":"23821548","id":"PMC_23821548","title":"RLIP76 protein knockdown attenuates obesity due to a high-fat diet.","date":"2013","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/23821548","citation_count":21,"is_preprint":false},{"pmid":"18789326","id":"PMC_18789326","title":"Diminished drug transport and augmented radiation sensitivity caused by loss of RLIP76.","date":"2008","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/18789326","citation_count":20,"is_preprint":false},{"pmid":"30136444","id":"PMC_30136444","title":"2'-Hydroxyflavanone inhibits in vitro and in vivo growth of breast cancer cells by targeting RLIP76.","date":"2018","source":"Molecular carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/30136444","citation_count":20,"is_preprint":false},{"pmid":"22319010","id":"PMC_22319010","title":"Dynamics of the subcellular localization of RalBP1/RLIP through the cell cycle: the role of targeting signals and of protein-protein interactions.","date":"2012","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/22319010","citation_count":19,"is_preprint":false},{"pmid":"25450693","id":"PMC_25450693","title":"The RLIP76 N-terminus binds ARNO to regulate PI 3-kinase, Arf6 and Rac signaling, cell spreading and migration.","date":"2014","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/25450693","citation_count":19,"is_preprint":false},{"pmid":"31336396","id":"PMC_31336396","title":"RALBP1 regulates oral cancer cells via Akt and is a novel target of miR-148a-3p and miR-148b-3p.","date":"2019","source":"Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology","url":"https://pubmed.ncbi.nlm.nih.gov/31336396","citation_count":19,"is_preprint":false},{"pmid":"26975227","id":"PMC_26975227","title":"Pharmacogenetics of ABCB5, ABCC5 and RLIP76 and doxorubicin pharmacokinetics in Asian breast cancer patients.","date":"2016","source":"The pharmacogenomics journal","url":"https://pubmed.ncbi.nlm.nih.gov/26975227","citation_count":19,"is_preprint":false},{"pmid":"11732624","id":"PMC_11732624","title":"Purification and functional reconstitution of intact ral-binding Gtpase activating protein, RLIP76, in artificial liposomes.","date":"2001","source":"Acta biochimica Polonica","url":"https://pubmed.ncbi.nlm.nih.gov/11732624","citation_count":18,"is_preprint":false},{"pmid":"29719590","id":"PMC_29719590","title":"2'-Hydroxyflavanone effectively targets RLIP76-mediated drug transport and regulates critical signaling networks in breast cancer.","date":"2018","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/29719590","citation_count":18,"is_preprint":false},{"pmid":"26498519","id":"PMC_26498519","title":"RLIP76 regulates Arf6-dependent cell spreading and migration by linking ARNO with activated R-Ras at recycling endosomes.","date":"2015","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/26498519","citation_count":17,"is_preprint":false},{"pmid":"28580172","id":"PMC_28580172","title":"RalBP1 and p19-VHL play an oncogenic role, and p30-VHL plays a tumor suppressor role during the blebbishield emergency program.","date":"2017","source":"Cell death discovery","url":"https://pubmed.ncbi.nlm.nih.gov/28580172","citation_count":17,"is_preprint":false},{"pmid":"26406496","id":"PMC_26406496","title":"Inflammation Modulates RLIP76/RALBP1 Electrophile-Glutathione Conjugate Transporter and Housekeeping Genes in Human Blood-Brain Barrier Endothelial Cells.","date":"2015","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/26406496","citation_count":15,"is_preprint":false},{"pmid":"25213293","id":"PMC_25213293","title":"RLIP76 blockade by siRNA inhibits proliferation, enhances apoptosis, and suppresses invasion in HT29 colon cancer cells.","date":"2015","source":"Cell biochemistry and biophysics","url":"https://pubmed.ncbi.nlm.nih.gov/25213293","citation_count":15,"is_preprint":false},{"pmid":"24450627","id":"PMC_24450627","title":"Structure and function of RLIP76 (RalBP1): an intersection point between Ras and Rho signalling.","date":"2014","source":"Biochemical Society transactions","url":"https://pubmed.ncbi.nlm.nih.gov/24450627","citation_count":14,"is_preprint":false},{"pmid":"17706599","id":"PMC_17706599","title":"Mass spectroscopic phosphoprotein mapping of Ral binding protein 1 (RalBP1/Rip1/RLIP76).","date":"2007","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/17706599","citation_count":13,"is_preprint":false},{"pmid":"18086001","id":"PMC_18086001","title":"The association between polymorphisms in RLIP76 and drug response in epilepsy.","date":"2007","source":"Pharmacogenomics","url":"https://pubmed.ncbi.nlm.nih.gov/18086001","citation_count":13,"is_preprint":false},{"pmid":"26021465","id":"PMC_26021465","title":"RLIP76 Targeted Therapy for Kidney Cancer.","date":"2015","source":"Pharmaceutical research","url":"https://pubmed.ncbi.nlm.nih.gov/26021465","citation_count":12,"is_preprint":false},{"pmid":"35682775","id":"PMC_35682775","title":"Rlip76: An Unexplored Player in Neurodegeneration and Alzheimer's Disease?","date":"2022","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/35682775","citation_count":12,"is_preprint":false},{"pmid":"30999946","id":"PMC_30999946","title":"A potential function of RLIP76 in the ovarian corpus luteum.","date":"2019","source":"Journal of ovarian research","url":"https://pubmed.ncbi.nlm.nih.gov/30999946","citation_count":11,"is_preprint":false},{"pmid":"36812304","id":"PMC_36812304","title":"Regulation of cargo exocytosis by a Reps1-Ralbp1-RalA module.","date":"2023","source":"Science advances","url":"https://pubmed.ncbi.nlm.nih.gov/36812304","citation_count":11,"is_preprint":false},{"pmid":"26041289","id":"PMC_26041289","title":"Early Steps of Jaagsiekte Sheep Retrovirus-Mediated Cell Transformation Involve the Interaction between Env and the RALBP1 Cellular Protein.","date":"2015","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/26041289","citation_count":11,"is_preprint":false},{"pmid":"37926360","id":"PMC_37926360","title":"The role of RLIP76 in oxidative stress and mitochondrial dysfunction: Evidence based on autopsy brains from Alzheimer's disease patients.","date":"2023","source":"Biochimica et biophysica acta. Molecular basis of disease","url":"https://pubmed.ncbi.nlm.nih.gov/37926360","citation_count":11,"is_preprint":false},{"pmid":"23485460","id":"PMC_23485460","title":"Down-regulation of RalBP1 expression reduces seizure threshold and synaptic inhibition in mice.","date":"2013","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/23485460","citation_count":10,"is_preprint":false},{"pmid":"28386633","id":"PMC_28386633","title":"RLIP76 Inhibition: A Promising Developmental Therapy for Neuroblastoma.","date":"2017","source":"Pharmaceutical research","url":"https://pubmed.ncbi.nlm.nih.gov/28386633","citation_count":9,"is_preprint":false},{"pmid":"27572296","id":"PMC_27572296","title":"RLIP76 increases apoptosis through Akt/mTOR signaling pathway in gastric cancer.","date":"2016","source":"Oncology reports","url":"https://pubmed.ncbi.nlm.nih.gov/27572296","citation_count":9,"is_preprint":false},{"pmid":"24839008","id":"PMC_24839008","title":"Knockdown of RLIP76 expression by RNA interference inhibits proliferation, enhances apoptosis, and increases chemosensitivity to daunorubicin in U937 leukemia cells.","date":"2014","source":"Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/24839008","citation_count":9,"is_preprint":false},{"pmid":"27473470","id":"PMC_27473470","title":"RLIP76 Depletion Enhances Autophagic Flux in U251 Cells.","date":"2016","source":"Cellular and molecular neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/27473470","citation_count":8,"is_preprint":false},{"pmid":"34064388","id":"PMC_34064388","title":"RLIP76: A Structural and Functional Triumvirate.","date":"2021","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/34064388","citation_count":7,"is_preprint":false},{"pmid":"25419163","id":"PMC_25419163","title":"Emerging treatments in lung cancer - targeting the RLIP76 molecular transporter.","date":"2013","source":"Lung Cancer (Auckland, N.Z.)","url":"https://pubmed.ncbi.nlm.nih.gov/25419163","citation_count":7,"is_preprint":false},{"pmid":"38325792","id":"PMC_38325792","title":"Pterostilbene and 6-shogaol exhibit inhibitory effects on sunitinib resistance and motility by suppressing the RLIP76-initiated Ras/ERK and Akt/mTOR pathways in renal cancer cells.","date":"2024","source":"European journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/38325792","citation_count":7,"is_preprint":false},{"pmid":"34283045","id":"PMC_34283045","title":"Haploinsufficiency Interactions between RALBP1 and p53 in ERBB2 and PyVT Models of Mouse Mammary Carcinogenesis.","date":"2021","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/34283045","citation_count":6,"is_preprint":false},{"pmid":"21686269","id":"PMC_21686269","title":"RLIP76 (RalBP1): The first piece of the structural puzzle.","date":"2010","source":"Small GTPases","url":"https://pubmed.ncbi.nlm.nih.gov/21686269","citation_count":6,"is_preprint":false},{"pmid":"33214225","id":"PMC_33214225","title":"Affinity maturation of the RLIP76 Ral binding domain to inform the design of stapled peptides targeting the Ral GTPases.","date":"2020","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/33214225","citation_count":6,"is_preprint":false},{"pmid":"25993541","id":"PMC_25993541","title":"Overexpression of RLIP76 Required for Proliferation in Meningioma Is Associated with Recurrence.","date":"2015","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/25993541","citation_count":5,"is_preprint":false},{"pmid":"28537681","id":"PMC_28537681","title":"RLIP76 silencing inhibits cell proliferation and invasion in melanoma cell line A375.","date":"2017","source":"European review for medical and pharmacological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/28537681","citation_count":5,"is_preprint":false},{"pmid":"22413001","id":"PMC_22413001","title":"Identification and characterization of the RLIP/RALBP1 interacting protein Xreps1 in Xenopus laevis early development.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22413001","citation_count":5,"is_preprint":false},{"pmid":"35325436","id":"PMC_35325436","title":"The ABCB1, ABCC2 and RALBP1 polymorphisms are associated with carbamazepine response in epileptic patient: a systematic review.","date":"2022","source":"Acta neurologica Belgica","url":"https://pubmed.ncbi.nlm.nih.gov/35325436","citation_count":5,"is_preprint":false},{"pmid":"35998001","id":"PMC_35998001","title":"Crucial Role of RLIP76 in Promoting Glycolysis and Tumorigenesis by Stabilization of HIF-1α in Glioma Cells Under Hypoxia.","date":"2022","source":"Molecular neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/35998001","citation_count":4,"is_preprint":false},{"pmid":"26462890","id":"PMC_26462890","title":"[Role and clinical significance of RLIP76 in regulation of multi-drug resistance of small cell lung cancer].","date":"2015","source":"Zhonghua zhong liu za zhi [Chinese journal of oncology]","url":"https://pubmed.ncbi.nlm.nih.gov/26462890","citation_count":4,"is_preprint":false},{"pmid":"27633085","id":"PMC_27633085","title":"Downregulation of RLIP76 is associated with vincristine resistance in human colorectal cancer HCT-8/VCR cells.","date":"2016","source":"International journal of oncology","url":"https://pubmed.ncbi.nlm.nih.gov/27633085","citation_count":4,"is_preprint":false},{"pmid":"19636899","id":"PMC_19636899","title":"1H, 13C and 15N resonance assignments for the active conformation of the small G protein RalB in complex with its effector RLIP76.","date":"2008","source":"Biomolecular NMR assignments","url":"https://pubmed.ncbi.nlm.nih.gov/19636899","citation_count":4,"is_preprint":false},{"pmid":"21915608","id":"PMC_21915608","title":"1H, 13C and 15N resonance assignments of the GTPase-activating (GAP) and Ral binding domains (GBD) of RLIP76 (RalBP1).","date":"2011","source":"Biomolecular NMR assignments","url":"https://pubmed.ncbi.nlm.nih.gov/21915608","citation_count":3,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":52696,"output_tokens":8382,"usd":0.141909,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":17870,"output_tokens":5458,"usd":0.1129,"stage2_stop_reason":"end_turn"},"total_usd":0.254809,"stage1_batch_id":"msgbatch_01CNoDbkChHEkgrJnL7BwtGJ","stage2_batch_id":"msgbatch_016Y4x9E9Wg5VQDANj9quSQD","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1995,\n      \"finding\": \"RLIP76 (RLIP1) was identified as a direct effector of activated RalA via its effector domain; it also contains a RhoGAP domain that displays GAP activity toward Rac1 and CDC42 but not RhoA, and this GAP region is not required for RalA binding.\",\n      \"method\": \"Two-hybrid screen, purified protein biochemical GAP assay, binding studies with purified RalA\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro biochemical GAP assay with purified proteins plus two-hybrid genetic interaction; foundational study replicated by subsequent structural and biochemical work\",\n      \"pmids\": [\"7673236\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"RLIP76 is identical to the previously characterized DNP-SG ATPase and catalyzes ATP-dependent transport of glutathione conjugates (GS-HNE, LTC4, DNP-SG) and doxorubicin when reconstituted into proteoliposomes; it has inherent ATPase activity stimulated by these substrates; transfection into K562 cells confers doxorubicin resistance.\",\n      \"method\": \"cDNA cloning and sequencing; E. coli expression and purification; ATPase assays; proteoliposome reconstitution transport assays; cell transfection with drug resistance/efflux readout\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro reconstitution with purified recombinant protein plus cellular functional validation; replicated across multiple subsequent studies\",\n      \"pmids\": [\"10924126\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"RLIP76 interacts with Mu2, the medium chain of the AP2 clathrin adaptor complex, both in vitro and in vivo as an endogenous complex; activated Ral interferes with transferrin receptor and EGF receptor endocytosis in HeLa cells, linking the Ral-RLIP76 pathway to clathrin-mediated endocytosis.\",\n      \"method\": \"Two-hybrid assay; co-immunoprecipitation of endogenous proteins; receptor endocytosis assay in cells expressing activated Ral\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal Co-IP of endogenous proteins plus functional endocytosis assay; replicated in subsequent studies\",\n      \"pmids\": [\"10910768\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"RalBP1 binds a novel ~85 kDa EH-domain protein, Reps1, at a site distinct from the Ral-binding site; Reps1 is tyrosine-phosphorylated in response to EGF and can associate with SH3 domains of Crk and Grb2.\",\n      \"method\": \"Two-hybrid cloning; in-cell EGF stimulation/phosphorylation assay; SH3 domain binding assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — two-hybrid plus cell-based phosphorylation evidence; single lab, foundational study\",\n      \"pmids\": [\"9395447\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"RLIP76 has two ATP-binding sites: (69)GKKKGK(74) in the N-terminal fragment and (418)GGIKDLSK(425) in the C-terminal fragment; mutation of K74 or K425 to Met abrogates ATPase activity and ATP binding; transport of doxorubicin and colchicine can be reconstituted by co-mixing N- and C-terminal fragments but not by either alone or by the ATPase-dead mutants.\",\n      \"method\": \"Deletion mutagenesis; photoaffinity labeling with 8-azido-ATP; ATPase assays; proteoliposome reconstitution transport assays\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — mutagenesis of active-site residues combined with reconstitution assays in a single rigorous study\",\n      \"pmids\": [\"11300797\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"RLIP76 is the predominant ATP-dependent transporter of glutathione conjugates (GS-HNE, LTC4, DNP-SG) and doxorubicin in human erythrocytes; anti-RLIP76 antibodies inhibit ~70% of transport in inside-out vesicles, whereas anti-MRP1 or anti-Pgp antibodies have no effect.\",\n      \"method\": \"Western blot; immunohistochemistry; antibody-mediated inhibition of transport in erythrocyte inside-out vesicles\",\n      \"journal\": \"Archives of biochemistry and biophysics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — quantitative immunotitration of transport activity with specific antibodies in native membrane vesicles; corroborated by multiple independent studies\",\n      \"pmids\": [\"11437348\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Mild oxidative or heat stress induces RLIP76 expression in K562 and multiple other cell lines, leading to increased GS-HNE efflux; cells pre-conditioned with stress acquire resistance to 4-HNE- and H2O2-mediated apoptosis; coating cells with anti-RLIP76 IgG (blocking GS-HNE efflux) abrogates this protection, demonstrating that RLIP76-mediated GS-HNE transport is the mechanistic basis of acquired stress resistance.\",\n      \"method\": \"Western blot (induction); GS-HNE efflux assay; cell surface antibody coating; apoptosis/caspase-3 and JNK activation assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — antibody loss-of-function experiment with defined transport and apoptosis readouts; replicated across multiple cell lines\",\n      \"pmids\": [\"11522795\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Amino acids 154–219, and specifically the segment 171–185, constitute the membrane-anchoring domain of RLIP76; deletion of this region reduces hydrophobicity, membrane incorporation into liposomes, and transport activity toward doxorubicin and DNP-SG; the region co-localizes with HER2/Neu at the cell surface and is necessary for surface expression.\",\n      \"method\": \"Deletion mutagenesis; detergent/aqueous partitioning assay; proteoliposome reconstitution; confocal immunohistochemistry; siRNA depletion of endogenous RLIP76 in transfected cells\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — mutagenesis combined with reconstitution transport assays and direct localization imaging in a single study\",\n      \"pmids\": [\"15610018\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"PKCα phosphorylates RLIP76 at T297 and S509; phosphorylation at T297 increases doxorubicin transport activity approximately 2-fold and confers sensitivity to tryptic cleavage at R293; RLIP76 from NSCLC (primarily phosphorylated) has ~2-fold higher specific activity for doxorubicin transport than SCLC RLIP76.\",\n      \"method\": \"Deletion mutant analysis; in vitro PKCα phosphorylation; transport activity assays with purified RLIP76 from cell lines; tryptic digest analysis\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — site-directed mutagenesis combined with in vitro kinase assay and functional transport readout\",\n      \"pmids\": [\"16087181\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"PKCα phosphorylates RLIP76 and increases its LTC4 transport activity 2–3-fold; proteoliposomes reconstituted with RLIP76 catalyze ATP-dependent LTC4 transport (Km ATP ~5.1 mM; Km LTC4 ~210 nM; Vmax ~3.2 nmol/min/mg); anti-RLIP76 antibodies inhibit 67–81% of LTC4 transport in cancer cell membrane vesicles.\",\n      \"method\": \"In vitro PKCα phosphorylation; proteoliposome reconstitution transport assays; antibody immunotitration of transport in cell membrane vesicles\",\n      \"journal\": \"International journal of cancer\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — reconstitution assay with kinase modification plus immunotitration in native membranes\",\n      \"pmids\": [\"15386349\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"RLIP76 is a direct effector of R-Ras (binds R-Ras in a GTP-dependent manner) but does not associate with H-Ras or Rap1A; RLIP76 is required for adhesion-induced Rac activation and resulting cell spreading and migration; RLIP76 mediates these effects through adhesion-induced Arf6 GTPase activation, and activated Arf6 can bypass the requirement for RLIP76.\",\n      \"method\": \"GTP-dependent pulldown/binding assay; siRNA knockdown with cell spreading and migration assays; epistasis by Arf6 activation rescue\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — GTP-dependent direct binding combined with siRNA epistasis and Arf6 rescue in a single study\",\n      \"pmids\": [\"16966426\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"HSF-1 causes specific, saturable inhibition of RLIP76 transport activity; combined HSF-1 and POB1 binding causes nearly complete inhibition; RLIP76 sequesters HSF-1 in the cellular cytoskeleton, and membrane-bound RLIP76 activity is inhibited by HSF-1.\",\n      \"method\": \"In vitro transport inhibition assays with purified proteins; over-expression of HSF-1/POB1 with apoptosis readout in lung cancer cells\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct transport inhibition assay with purified proteins plus cellular over-expression; single lab\",\n      \"pmids\": [\"18474607\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"POB1 (REPS2) directly inhibits RLIP76-mediated doxorubicin and DNP-SG transport in a concentration-dependent manner through direct binding to RLIP76; a POB1 deletion mutant lacking the RLIP76-binding domain does not inhibit transport and does not cause apoptosis upon liposomal delivery to cancer cells.\",\n      \"method\": \"Purified protein transport inhibition assay; liposomal delivery of POB1 with apoptosis and drug efflux readouts; deletion mutant analysis\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct transport assay with purified proteins plus domain-deletion controls; single lab\",\n      \"pmids\": [\"15707977\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Cdc2 (CDK1) directly inhibits RLIP76-mediated transport of doxorubicin and DNP-SG in a concentration-dependent manner in reconstituted proteoliposomes; liposomal delivery of cdc2 to H358 cells increases intracellular doxorubicin accumulation and induces apoptosis.\",\n      \"method\": \"Purified protein transport inhibition assay in reconstituted liposomes; liposomal cdc2 delivery with intracellular drug accumulation and apoptosis assays\",\n      \"journal\": \"Cancer letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vitro reconstitution assay plus cell-based functional validation; single lab\",\n      \"pmids\": [\"19375851\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"RalBP1 is translocated to synapses upon NMDA receptor activation via stimulation of RalA; NMDAR activation also dephosphorylates RalBP1, promoting its interaction with the postsynaptic scaffolding protein PSD-95; both the RalA interaction and the PSD-95 interaction are required for NMDAR-dependent AMPA receptor endocytosis and LTD, and together they are sufficient to induce AMPAR endocytosis in the absence of NMDAR activation.\",\n      \"method\": \"Co-immunoprecipitation; NMDAR activation/dephosphorylation assays; siRNA knockdown with AMPAR endocytosis and LTD electrophysiology readouts; rescue experiments\",\n      \"journal\": \"PLoS biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal Co-IP, dephosphorylation-binding assay, siRNA epistasis, and electrophysiological LTD readout in a single study\",\n      \"pmids\": [\"19823667\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"The Ral-binding domain (RBD) of RLIP76 forms a coiled-coil motif; the RBD-RalB complex structure reveals that RLIP76 contacts both nucleotide-sensitive switch regions of RalB; RLIP76 competes with Sec5 and Exo84 exocyst components for Ral binding with similar affinities in vitro.\",\n      \"method\": \"NMR structure determination of RBD alone; X-ray/NMR co-structure of RBD–RalB complex; mutagenesis of RalB interface residues with affinity measurements\",\n      \"journal\": \"Structure\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — atomic-resolution structure of protein complex plus mutagenesis validation of key interface residues\",\n      \"pmids\": [\"20696399\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Aurora A phosphorylates RALA at Ser194 during mitosis, relocalizing RALA to mitochondria where it concentrates RALBP1 and DRP1; RALBP1 is associated with cyclin B–CDK1 kinase activity that phosphorylates DRP1 Ser616; disrupting RALA or RALBP1 abolishes mitochondrial fission at mitosis, causes improper mitochondrial segregation, and reduces ATP levels.\",\n      \"method\": \"Phospho-specific antibodies; mitochondrial fractionation; siRNA knockdown with live imaging and mitochondrial fission/DRP1 localization readouts; CDK1 kinase activity co-purification assay\",\n      \"journal\": \"Nature cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (fractionation, imaging, kinase assay, siRNA epistasis) in a single study; highly cited; independently coherent mechanistic model\",\n      \"pmids\": [\"21822277\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"RLIP76-mediated glutathione-conjugate (GS-E) transport is required for clathrin-dependent endocytosis (CDE); RLIP76 mutants deficient in GS-E binding fail to rescue CDE in RLIP76(-/-) MEFs; RLIP76 depletion blocks downstream EGF signaling in a CDE-dependent manner; RLIP76(-/-) mice are resistant to chemical carcinogenesis (benzo[a]pyrene, DMBA, phorbol esters), and this resistance can be restored by topical RLIP76 protein application.\",\n      \"method\": \"RLIP76 mutant analysis in knockout MEFs; CDE assay; EGF signaling Western blots; in vivo chemical carcinogenesis in RLIP76(-/-) mice\",\n      \"journal\": \"Molecular cancer therapeutics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — loss-of-function in knockout mice, mutant rescue in MEFs, and epistasis via CDE pathway; multiple orthogonal readouts\",\n      \"pmids\": [\"21220488\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"RalB-dependent invadopodium formation in PDAC cells requires RalBP1/RLIP76 but not the Sec5/Exo84 exocyst effectors; the requirement for RalBP1 is independent of its RhoGAP activity but depends on its ATPase function, identifying a novel RalB→RalBP1(ATPase) signaling axis for invadopodium formation.\",\n      \"method\": \"siRNA knockdown of Ral effectors; invadopodium formation assay; RalBP1 domain-specific rescue (ATPase mutant vs GAP mutant)\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — domain-specific mutant rescue clearly separates ATPase from GAP function; clean epistasis design\",\n      \"pmids\": [\"22331470\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"RLIP76 is required for angiogenesis and neovascularization of solid tumors; in RLIP76(-/-) mice tumor vascular volumes are diminished, vessels are fewer, shorter and narrower; endothelial cells from RLIP76(-/-) mice show defects in migration, proliferation, and cord formation in vitro.\",\n      \"method\": \"RLIP76(-/-) mouse tumor implantation; X-ray microcomputed tomography of tumor vasculature; isolated endothelial cell functional assays (migration, proliferation, Matrigel cord formation)\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic loss-of-function in mice with quantitative vascular imaging plus isolated cell mechanistic assays\",\n      \"pmids\": [\"22902412\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"RalBP1 is detected in the nucleus of interphase cells via nuclear localization sequences in the N-terminal third of the protein; a C-terminal coiled-coil mediates nuclear retention in Xenopus embryos; RalBP1 localizes to the actin cytoskeleton in an active Ral-dependent manner; during mitosis it associates with the mitotic spindle and centrosome, a localization negatively regulated by active Ral.\",\n      \"method\": \"Immunolocalization of endogenous RalBP1; deletion mutant analysis; live imaging in Xenopus embryos; cell-cycle staging\",\n      \"journal\": \"FASEB journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — domain mapping combined with immunolocalization across multiple compartments and cell-cycle stages; no reconstitution\",\n      \"pmids\": [\"22319010\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"RLIP76 in glioma cells promotes proliferation and suppresses apoptosis through a Rac1-JNK signaling mechanism; constitutively active Rac1 rescues the effects of RLIP76 siRNA; the ATPase function of RLIP76 (not its RhoGAP activity) modulates Rac1 protein levels by regulating Rac1 ubiquitylation and degradation.\",\n      \"method\": \"Stable siRNA knockdown; constitutively active Rac1 rescue; Western blot for Rac1 ubiquitylation; JNK signaling assays; xenograft model\",\n      \"journal\": \"Carcinogenesis\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — rescue epistasis experiment plus ubiquitylation assay; single lab, needs independent replication\",\n      \"pmids\": [\"23276796\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"RLIP76 N-terminus (residues 1–180) binds ARNO (cytohesin-2, an Arf6 GEF); Ser29/Ser30 mutation blocks ARNO interaction and prevents RLIP76-dependent Arf6 activation, PI3K activation, cell spreading, and migration; Ser62 mutation blocks Rac1 activation without affecting ARNO interaction or Arf6 activation, indicating a second step in the pathway.\",\n      \"method\": \"Domain deletion and point mutation analysis; Co-IP; Arf6 and Rac1 activation assays; cell spreading and migration assays\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — systematic domain mapping with GTPase activation and cellular functional readouts; single lab\",\n      \"pmids\": [\"25450693\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"RLIP76 acts as a scaffold at recycling endosomes (Rab11-positive) by binding activated R-Ras via residues 180–192 and ARNO via the N-terminal domain (residues 1–180); RLIP76 recruits ARNO to recycling endosomes to activate Arf6, thereby promoting cell spreading and migration.\",\n      \"method\": \"Co-IP; domain-deletion mutant analysis; Rab11 colocalization imaging; Arf6 activation assay; cell spreading/migration assays with rescue\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP and domain mapping with endosomal localization and GTPase activation readouts; single lab\",\n      \"pmids\": [\"26498519\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"RLIP76 is required for HIF-1 transcriptional activity and VEGF expression/secretion in carcinoma and melanoma cells; RLIP76-depleted tumor conditioned medium cannot stimulate endothelial cell proliferation, migration, or Matrigel cord formation, and this is rescued by recombinant VEGF; RLIP76 is required for PI3-kinase activation that regulates HIF-1 activity, but does not affect HIF-1α expression or nuclear localization.\",\n      \"method\": \"siRNA knockdown; HIF-1 luciferase reporter assay; VEGF ELISA; conditioned medium transfer experiment with endothelial cell functional assays; PI3K activity assay\",\n      \"journal\": \"FASEB journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — siRNA epistasis with multiple functional readouts and conditioned-medium rescue; single lab\",\n      \"pmids\": [\"24928198\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Mass spectrometry identified 14 phosphorylation sites in RalBP1; 10 of the first 100 N-terminal residues are phosphorylated (9 Ser, 1 Thr); overexpression of RalB produces the largest changes in phosphorylation at S463 and S645.\",\n      \"method\": \"Mass spectrometric phosphoprotein mapping in UMUC-3 and 293T cells; RalB overexpression with comparative phosphorylation analysis\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct MS phosphosite mapping in two cell lines with functional protein overexpression comparison; single lab\",\n      \"pmids\": [\"17706599\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"p53 forms a specific, saturable complex with RLIP76 (shown by co-immunoprecipitation and immunofluorescence colocalization); p53 inhibits both basal and PKCα-stimulated RLIP76-mediated transport of GS-HNE and doxorubicin; loss of p53 in neuroblastoma results in RLIP76 overexpression and enhanced transport activity.\",\n      \"method\": \"Co-immunoprecipitation of purified proteins; immunofluorescence colocalization; in vitro transport inhibition assay; comparison of p53-WT vs p53-mutant cell lines\",\n      \"journal\": \"Cancer prevention research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct protein binding confirmed by both Co-IP and imaging, plus functional transport inhibition assay; single lab\",\n      \"pmids\": [\"21411502\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"PKCα-mediated mitogenesis requires RLIP76 as a downstream effector; RLIP76(-/-) MEFs are resistant to PKCα depletion-mediated growth inhibition and to the PKCα-dependent mitogen PMA; restoration of RLIP76 in RLIP76(-/-) MEFs rescues sensitivity to both effects.\",\n      \"method\": \"RLIP76(-/-) MEFs; PKCα depletion; PMA treatment; rescue with exogenous RLIP76 protein via liposomal delivery\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic knockout with defined mitogenic readout and protein rescue; single lab\",\n      \"pmids\": [\"16890208\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Affinity maturation of the RLIP76 Ral-binding domain identified substitutions that improve Ral binding >20-fold; two 1.5 Å co-crystal structures of tight-binding mutants with RalB defined key interface interactions; NMR confirmed the binding site of resulting stapled peptides on RalB; these peptides competed with multiple Ral-effector interactions in cellular lysates.\",\n      \"method\": \"Directed evolution/affinity maturation; X-ray co-crystallography (1.5 Å); NMR chemical shift mapping; competitive binding assays in cellular lysates\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — high-resolution crystal structures combined with mutagenesis affinity measurements and NMR validation in a single study\",\n      \"pmids\": [\"33214225\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Reps1 and Ralbp1 form a binary complex that recognizes vesicle-bound RalA in the exocytic pathway; RalA binding causes Reps1 release and formation of a Ralbp1–RalA binary complex; Ralbp1 selectively stabilizes GTP-bound RalA (GTP state stabilization), thereby promoting exocytosis and surface protein levels; this is distinct from classical effector function.\",\n      \"method\": \"Co-IP; GTP-dependent binding assays; surface protein level measurements; epistasis with exocyst complex\",\n      \"journal\": \"Science advances\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP and biochemical GTP-dependent binding assays define a novel GTPase regulatory mechanism; single study\",\n      \"pmids\": [\"36812304\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"RLIP76 directly binds HIF-1α in the nucleus and stabilizes it by alleviating HIF-1α ubiquitination under hypoxia, thereby activating HIF-1α target glycolytic genes GLUT1 and LDHA to promote glioma glycolysis and tumor development.\",\n      \"method\": \"Co-immunoprecipitation of RLIP76 and HIF-1α; ubiquitination assay; siRNA knockdown with GLUT1/LDHA Western blots; in vivo xenograft\",\n      \"journal\": \"Molecular neurobiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP plus ubiquitination assay and functional downstream gene readouts; single lab\",\n      \"pmids\": [\"35998001\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"RBD structure of RLIP76 reveals its coiled-coil binds both switch regions of RalB; the juxtaposed RhoGAP and RBD domains are held in fixed orientation by a rigid linker, allowing simultaneous engagement of Rho-family and Ral GTPases at the membrane.\",\n      \"method\": \"NMR resonance assignments; structural analysis of GAP-GBD di-domain\",\n      \"journal\": \"Biomolecular NMR assignments\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — NMR resonance assignments confirming domain arrangement; structural data without extensive mutagenesis validation in this paper alone\",\n      \"pmids\": [\"21915608\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"RALBP1/RLIP76 is a multifunctional effector of RalA/RalB (binding both switch regions via a coiled-coil Ral-binding domain) and R-Ras that bridges Ras-family and Rho-family signaling: its central RhoGAP domain inactivates Rac1 and CDC42; its N-terminal domain and two ATP-binding sites (GKKKGK74 and GGIKDLSK425) constitute a non-ABC transporter that actively exports glutathione-electrophile conjugates (GS-HNE, LTC4), doxorubicin, and other xenobiotics; at mitosis, Aurora A–phosphorylated RalA recruits RLIP76 and DRP1 to mitochondria where RLIP76-associated cyclin B–CDK1 phosphorylates DRP1-Ser616 to drive mitochondrial fission; RLIP76-mediated GS-E transport is mechanistically required for clathrin-dependent endocytosis and thereby regulates receptor signaling; RLIP76 scaffolds ARNO at recycling endosomes downstream of R-Ras to activate Arf6 and Rac1, driving cell spreading and migration; in neurons, regulated dephosphorylation of RLIP76 and its interaction with RalA and PSD-95 control AMPA receptor endocytosis during LTD; p53 is a direct allosteric inhibitor of RLIP76 transport activity; and RLIP76 stabilizes HIF-1α by blocking its ubiquitination, linking it to hypoxic glycolysis and tumor angiogenesis.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"RALBP1 (RLIP76) is a multifunctional Ral effector that couples Ras-family GTPase signaling to membrane transport, endocytosis, and cytoskeletal remodeling [#0, #15]. It binds activated RalA/RalB through a coiled-coil Ral-binding domain that contacts both nucleotide-sensitive switch regions, competing with the Sec5 and Exo84 exocyst effectors for Ral occupancy [#15, #28], and its juxtaposed RhoGAP domain inactivates Rac1 and CDC42 but not RhoA [#0, #31]. Independently of its Ral-binding and GAP functions, RLIP76 is a non-ABC ATP-dependent transporter built from two ATP-binding sites and a membrane-anchoring domain that exports glutathione-electrophile conjugates (GS-HNE, LTC4, DNP-SG) and xenobiotics including doxorubicin; reconstitution requires intact N- and C-terminal ATPase fragments, and this activity is the predominant glutathione-conjugate efflux route in human erythrocytes [#1, #4, #5, #7]. This transport activity underlies acquired oxidative-stress resistance, drug resistance, and is mechanistically required for clathrin-dependent endocytosis and downstream EGF receptor signaling, with RLIP76-null mice resistant to chemical carcinogenesis [#6, #17]. RLIP76 also functions as a scaffold: as a GTP-dependent effector of R-Ras it recruits the Arf6 GEF ARNO to Rab11 recycling endosomes to activate Arf6 and Rac1, driving cell spreading and migration [#10, #22, #23]; in neurons it is recruited to synapses by RalA and binds PSD-95 to drive NMDAR-dependent AMPA receptor endocytosis during long-term depression [#14]; and at mitosis it is recruited with DRP1 to mitochondria where associated cyclin B–CDK1 phosphorylates DRP1-Ser616 to drive mitochondrial fission [#16]. Through these activities RLIP76 supports tumor proliferation, invadopodium formation, angiogenesis, and HIF-1-driven glycolysis [#18, #19, #24, #30]. Its transport activity is regulated by PKCα phosphorylation and is directly inhibited by p53 [#8, #26].\"\n,\n  \"teleology\": [\n    {\n      \"year\": 1995,\n      \"claim\": \"Established RALBP1 as a direct effector of activated RalA that also carries Rho-family GAP activity, defining it as a node linking Ral and Rho signaling.\",\n      \"evidence\": \"Two-hybrid screen with purified-protein GAP assays against Rac1, CDC42, and RhoA\",\n      \"pmids\": [\"7673236\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cellular consequences of Rac1/CDC42 inactivation not defined\", \"Did not address any transport or scaffolding function\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Revealed that RLIP76 is identical to the DNP-SG ATPase and is an ATP-dependent transporter of glutathione conjugates and doxorubicin, a function entirely separate from its Ral effector role.\",\n      \"evidence\": \"cDNA cloning, recombinant purification, proteoliposome reconstitution transport assays, and drug-resistance transfection in K562 cells\",\n      \"pmids\": [\"10924126\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of substrate recognition unknown\", \"Relationship between transport and Ral binding undefined\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Connected the Ral–RLIP76 pathway to clathrin-mediated endocytosis by identifying the AP2 adaptor subunit Mu2 as a partner.\",\n      \"evidence\": \"Two-hybrid, endogenous Co-IP, and receptor endocytosis assays in HeLa cells expressing activated Ral\",\n      \"pmids\": [\"10910768\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not show whether transport activity is required for endocytosis\", \"Direct AP2-Mu2 interface not mapped\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Defined the bipartite ATPase architecture (two ATP-binding sites) required for transport, showing reconstitution needs both N- and C-terminal fragments.\",\n      \"evidence\": \"Deletion mutagenesis, 8-azido-ATP photoaffinity labeling, and proteoliposome reconstitution of doxorubicin/colchicine transport\",\n      \"pmids\": [\"11300797\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No atomic structure of the transport module\", \"Stoichiometry of the functional transporter unresolved\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Quantified RLIP76 as the dominant glutathione-conjugate/doxorubicin transporter in native erythrocyte membranes, distinguishing it from MRP1 and Pgp.\",\n      \"evidence\": \"Antibody immunotitration of transport in erythrocyte inside-out vesicles\",\n      \"pmids\": [\"11437348\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Contribution in other tissues not quantified in this study\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Demonstrated that RLIP76-mediated GS-HNE efflux is the mechanistic basis of stress-induced apoptosis resistance, linking the transporter to cellular stress adaptation.\",\n      \"evidence\": \"Stress-induced expression, GS-HNE efflux assays, and anti-RLIP76 surface-coating loss-of-function with apoptosis readouts across cell lines\",\n      \"pmids\": [\"11522795\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Transcriptional control of stress induction not defined\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Mapped the membrane-anchoring domain (residues 154–219) needed for membrane incorporation, surface expression, and transport.\",\n      \"evidence\": \"Deletion mutagenesis, partitioning assays, reconstitution, and confocal colocalization with HER2/Neu\",\n      \"pmids\": [\"15610018\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Topology of membrane insertion not resolved\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Identified PKCα phosphorylation at T297/S509 as a positive regulator of transport activity, providing a signaling input to drug efflux.\",\n      \"evidence\": \"In vitro PKCα phosphorylation, site mutagenesis, and transport assays comparing NSCLC vs SCLC RLIP76\",\n      \"pmids\": [\"16087181\", \"15386349\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo phosphorylation stoichiometry not measured\", \"Structural effect of phosphorylation on transport unknown\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Established RLIP76 as a GTP-dependent R-Ras effector required for adhesion-induced Rac and Arf6 activation, driving cell spreading and migration.\",\n      \"evidence\": \"GTP-dependent pulldowns, siRNA knockdown with spreading/migration assays, and Arf6 rescue epistasis\",\n      \"pmids\": [\"16966426\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism linking RLIP76 to Arf6 activation not yet molecular\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Defined a neuronal role: RalA-driven synaptic recruitment and dephosphorylation-dependent PSD-95 binding control AMPAR endocytosis during LTD.\",\n      \"evidence\": \"Co-IP, dephosphorylation-binding assays, siRNA rescue, and LTD electrophysiology\",\n      \"pmids\": [\"19823667\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Phosphatase responsible for dephosphorylation not identified\", \"Link to the transport/endocytosis machinery not resolved\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Solved the Ral-binding domain structure, showing a coiled-coil that engages both RalB switch regions and competes with exocyst effectors.\",\n      \"evidence\": \"NMR/X-ray structures of RBD and RBD–RalB complex with interface mutagenesis and affinity measurements\",\n      \"pmids\": [\"20696399\", \"21915608\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional consequences of effector competition in cells not quantified\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Demonstrated that GS-E transport activity is mechanistically required for clathrin-dependent endocytosis and EGF signaling, and that RLIP76 loss confers carcinogenesis resistance in vivo.\",\n      \"evidence\": \"Mutant rescue in RLIP76(-/-) MEFs, CDE assays, EGF signaling blots, and chemical carcinogenesis in knockout mice\",\n      \"pmids\": [\"21220488\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular link between glutathione-conjugate flux and clathrin machinery unresolved\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Defined the mitotic mitochondrial-fission axis in which Aurora A–phosphorylated RalA recruits RLIP76 and DRP1, with associated cyclin B–CDK1 phosphorylating DRP1-Ser616.\",\n      \"evidence\": \"Phospho-specific antibodies, mitochondrial fractionation, live imaging, CDK1 kinase co-purification, and siRNA epistasis\",\n      \"pmids\": [\"21822277\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How RLIP76 physically tethers cyclin B–CDK1 to DRP1 not defined\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Separated RLIP76 functions in cancer, showing its ATPase (not GAP) activity drives RalB-dependent invadopodium formation and tumor angiogenesis.\",\n      \"evidence\": \"Domain-specific rescue in PDAC invadopodium assays and RLIP76(-/-) mouse tumor vasculature with isolated endothelial cell assays\",\n      \"pmids\": [\"22331470\", \"22902412\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Transport substrate relevant to invadopodia/angiogenesis not identified\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Identified ARNO (cytohesin-2) as an N-terminal partner and dissected phosphosite-controlled steps for Arf6 versus Rac1 activation in spreading and migration.\",\n      \"evidence\": \"Domain mapping, point mutation (Ser29/30, Ser62), Co-IP, and GTPase activation/cell motility assays\",\n      \"pmids\": [\"25450693\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab\", \"Kinases controlling these serines not identified\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Showed RLIP76 acts as a recycling-endosome scaffold bridging activated R-Ras and ARNO to localize Arf6 activation, integrating earlier transport and migration findings.\",\n      \"evidence\": \"Co-IP, domain mapping, Rab11 colocalization, and Arf6/migration rescue assays\",\n      \"pmids\": [\"26498519\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab\", \"Relationship to the transport-dependent endocytosis role not reconciled\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Linked RLIP76 to hypoxic metabolism by showing it directly binds and stabilizes HIF-1α to activate GLUT1/LDHA and promote glioma glycolysis.\",\n      \"evidence\": \"Co-IP, ubiquitination assays, siRNA with GLUT1/LDHA blots, and xenografts\",\n      \"pmids\": [\"35998001\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab\", \"Mechanism by which RLIP76 blocks HIF-1α ubiquitination unresolved\", \"Apparent tension with earlier report that RLIP76 does not affect HIF-1α expression/localization (24928198) not reconciled\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Revealed a non-effector GTPase-regulatory mode in which a Reps1–Ralbp1 complex selectively stabilizes GTP-bound RalA on exocytic vesicles to promote surface protein delivery.\",\n      \"evidence\": \"Co-IP, GTP-dependent binding, surface protein measurements, and exocyst epistasis\",\n      \"pmids\": [\"36812304\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single study\", \"Structural basis of GTP-state stabilization unknown\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How RLIP76's distinct activities — glutathione-conjugate transport, RhoGAP, Ral/R-Ras effector scaffolding, and GTP-state stabilization — are spatially and temporally coordinated within a single protein remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No full-length structure integrating transport, GAP, and Ral-binding modules\", \"Mechanistic link between glutathione-conjugate flux and clathrin endocytosis unexplained\", \"Physiological hierarchy among transport vs scaffold functions in vivo undefined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140657\", \"supporting_discovery_ids\": [1, 4, 5, 9]},\n      {\"term_id\": \"GO:0005215\", \"supporting_discovery_ids\": [1, 4, 5, 7, 9]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [0, 29]},\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [0, 10, 15]},\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [22, 23, 14]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [7, 5]},\n      {\"term_id\": \"GO:0005768\", \"supporting_discovery_ids\": [23, 2]},\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [16]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [20, 30]},\n      {\"term_id\": \"GO:0005856\", \"supporting_discovery_ids\": [20, 11]},\n      {\"term_id\": \"GO:0005815\", \"supporting_discovery_ids\": [20]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-5653656\", \"supporting_discovery_ids\": [2, 17]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 10, 22, 23]},\n      {\"term_id\": \"R-HSA-382551\", \"supporting_discovery_ids\": [1, 4, 5]},\n      {\"term_id\": \"R-HSA-1640170\", \"supporting_discovery_ids\": [16]},\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [14]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"RALA\", \"RALB\", \"RRAS\", \"REPS1\", \"REPS2\", \"PSD95\", \"ARNO\", \"TP53\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":7,"faith_total":7,"faith_pct":100.0}}